Disease
N. asteroides causes nocardiosis.
Important Properties & Pathogenesis
Nocardia species are aerobes and are found in the environment, particularly in the soil. In immunocompromised individuals, they can produce lung infection and may disseminate. In tis sues, Nocardia species are thin, branching filaments that are gram-positive on Gram stain.
Many isolates of N. asteroides are weakly acid-fast (i.e., the staining process uses a weaker solution of hydrochloric acid to decolorize than that used in the stain for mycobacteria). If the regular-strength acid is used, N. asteroides will decolorize. N. asteroides is weakly acid-fast because it contains a layer of mycolic acid in its cell wall, similar to, but less than, the mycobacteria.
Clinical Findings
N. asteroides typically causes pneumonia, lung abscess with cavity formation, lung nodules, or empyema. From the lung, the organism can spread to various organs, notably the brain, where it causes brain abscess. Disease occurs most often in immunocompromised individuals, especially those with reduced cell mediated immunity.
Nocardia brasiliensis, a different species of Nocardia, causes skin infections in the southern regions of the United States and mycetoma, usually in tropical regions.
Laboratory Diagnosis
Diagnosis in the laboratory involves (1) seeing branching rods or filaments that are gram-positive (see Figure 1) or weakly acid-fast in an acid-fast stain and (2) seeing aerobic growth on bacteriologic media in a few days. Molecular methods such as PCR, MALDI-TOV, and metagenomic next-generation sequencing have increased diagnostic sensitivity and timeliness, but are not widely available.

Fig1. Nocardia asteroides. Gram stain. Arrow points to area of filaments of gram-positive rods. (Used with permission from Dr. Thomas F. Sellers, Public Health Image Library, Centers for Disease Control and Prevention.)
Treatment & Prevention
The drug of choice is trimethoprim-sulfamethoxazole. For the treatment of severe infections, a second drug, such as amikacin, imipenem, or ceftriaxone can be added, depending on results of susceptibility tests. A prolonged course of treatment, for example, 3 to 6 months, is often required. Surgical drainage may also be needed. Occasional drug resistance occurs. No vaccine or prophylactic drug is available.